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Proteolysis of the b C-terminal fragment (b-CTF) of
the amyloid precursor protein generates the Ab pep-
tides associated with Alzheimer’s disease. Familial
mutations in the b-CTF, such as the A21G Flemish
mutation, can increase Ab secretion. We establish
how the Flemish mutation alters the structure of
C55, the first 55 residues of the b-CTF, using FTIR
and solid-state NMR spectroscopy. We show that
the A21G mutation reduces b sheet structure of
C55 from Leu17 to Ala21, an inhibitory region near
the site of the mutation, and increases a-helical
structure from Gly25 to Gly29, in a region near the
membrane surface and thought to interact with
cholesterol. Cholesterol also increases Ab peptide
secretion, and we show that the incorporation of
cholesterol into model membranes enhances the
structural changes induced by the Flemish mutant,
suggesting a common link between familial muta-
tions and the cellular environment.
INTRODUCTION
The amyloid precursor protein (APP) is an integral membrane
protein with a single transmembrane (TM) domain that is ex-
pressed in a wide number of different cell types, including neu-
rons (Selkoe, 2004). Processing of APP occurs by the sequential
action of several proteases. Both a- and b-secretase first cleave
between the extracellular and the TM domains of APP to
generate an N-terminal soluble fragment (soluble aAPP or solu-
ble bAPP) and amembrane-anchored C-terminal fragment (a- or
b-CTF). The g-secretase complex cleaves the CTFs within their
TM domains. The cleavage of the b-CTF generates predomi-
nantly the Ab40 peptide, but both shorter and longer Ab peptides
are also produced. The major longer peptide generated, Ab42,
has a higher propensity to form aggregates than the shorter iso-
forms and is the most toxic peptide generated by g-cleavage
(Burdick et al., 1992).
Three clusters of familial Alzheimer’s disease (AD) mutations
in APP are located close to the a-, b-, and g-cleavage sites,Structure 22,respectively. Specific mutations within these clusters influence
the proteolytic processing of APP to favor increased Ab42 pro-
duction over the shorter Ab peptides or to favor an increase in
the total production of Ab peptides. The substrate numbering
is based on the APP695 isoform of APP. Asp597 corresponds
to the first residue (i.e., Asp1) of the b-CTF (Figure 1A).
A fourth cluster is located a few residues below the a-secre-
tase cleavage site at K16-L17. This cluster is comprised of the
A21G (Flemish), E22Q (Dutch), E22G (Arctic), E22K (Italian),
and D23N (Iowa) mutations (Grabowski et al., 2001; Hendriks
et al., 1992; Kamino et al., 1992; Levy et al., 1990), which have
very different effects on APP processing (De Jonghe et al.,
1998) and Ab peptide aggregation (Betts et al., 2008). The
A21G mutation appears to increase Ab production by approxi-
mately 2- to 4-fold, but not via a change in a-secretase cleavage
(De Jonghe et al., 1998; Tian et al., 2010). In contrast, mutations
at E22 and D23 do not markedly change the level of total
secreted Ab peptides (De Jonghe et al., 1998; Tian et al., 2010)
but rather increase the rate of fibril formation after the Ab pep-
tides are generated by proteolysis. To understand the diversity
of effects within this central cluster of mutations midway
between the b- and g-cleavage sites, we focus here on the
A21G Flemish mutation and address how the removal of a
single methyl group can have such a dramatic influence on Ab
production.
Several residues surrounding the A21G mutation have been
found to influence APP processing, although they are not asso-
ciated with early-onset AD. Yi and colleagues (Tian et al., 2010)
found that the L17-V18-F19-F20-A21 sequence is part of an
inhibitory motif that modulates g-secretase processing. Upon
deletion of this motif, the catalytic efficiency of g-secretase in-
creases 25-fold compared to the full-length b-CTF. They sug-
gested that the A21Gmutation might disrupt the inhibitory effect
of this region, implying that the interaction between APP and g-
secretase is altered upon mutation. In contrast, mutations in the
G25-S26-N27-K28 region, which is a few residues C-terminal to
position 21, induce the opposite effect. Ren et al. (2007) found
that mutations at Ser26 and Lys28 reduce secreted Ab40 and
Ab42 without a corresponding loss of the APP intracellular
domain cleavage product. Golde and colleagues (Kukar et al.,
2011) found that the K28A and K28Q mutations shift the major
cleavage site to the position of Gly33 from Val40. These results
suggest that the precise nature and location of the border region387–396, March 4, 2014 ª2014 Elsevier Ltd All rights reserved 387
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Figure 1. Increase of Ab Secretion in the A21G and LVFF to AAAA
Mutations
(A) Sequence of the extracellular and TM regions of the b-CTF. The b-CTF is
produced by b-secretase cleavage of APP. The first 28 amino acids form the
extracellular region of the b-CTF and contain the a-secretase cleavage site.
The TM domain (denoted by vertical dashed lines) contains the site of
g-secretase cleavage. Both the extracellular and TM regions contain sites of
familial AD mutations, shown as the single-letter amino acids below the
sequence.
(B) Comparison of the levels of Ab38, Ab40, and Ab42 produced by g-secre-
tase cleavage of the WT b-CTF, A21G, and LVFF to AAAA mutants.
(C) Comparison of the levels of Ab38, Ab40, and Ab42 produced by g-secre-
tase cleavage of WT C55 and the corresponding A21G and LVFF to AAAA
mutants.
Statistical significance was evaluated by one-way ANOVA followed by
Dunnett’s post hoc test. Values are the means ± SE, n > 5; *p < 0.05; **p < 0.01;
***p < 0.001, compared with control. See also Figure S1.
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Conformational Changes Induced by A21Gbetween the extracellular and TM domains can exert a substan-
tial effect on the position of g-cleavage within the TM domain.
The structure of the nonmutated, 99-residue b-CTF (also
referred to as C99) was determined in detergent micelles by
solution nuclear magnetic resonance (NMR) spectroscopy
(Beel et al., 2008). Helical structure was observed in the L17-
V18-F19-F20 (or LVFF) sequence, the hydrophobic TM domain,
and in the last 10 residues of the cytoplasmic sequence. The
LVFF region is of particular interest because of its possible role
as an inhibitory motif (Tian et al., 2010) and as a key element in
amyloid plaque formation by the Ab peptides (Inouye et al.,
2010). An open question is whether structural changes are
induced in the b-CTF upon the A21G mutation.
The A21G mutation may also influence the ability of the b-CTF
to associate as TM homodimers. Glycines are abundant in TM
helices of membrane proteins and the GxxxG sequence is well
known to be a dimerization motif (Lemmon et al., 1992). The
TM region of APP is unusual in containing three consecutive
GxxxG motifs. The A21G mutation generates a fourth consecu-
tive upstreammotif, which raises the possibility that themutation
influences TM helix dimerization. Several studies have targeted
these GxxxG sequences and found that mutations alter process-388 Structure 22, 387–396, March 4, 2014 ª2014 Elsevier Ltd All righing of the b-CTF (Kienlen-Campard et al., 2008; Munter et al.,
2007).
In addition, a cholesterol-binding site was identified in the jux-
tamembrane (JM) region of the b-CTF between the extracellular
and TM domains (Barrett et al., 2012). As with the A21G muta-
tion, the presence of cholesterol and cholesterol-rich domains
were linked to g-secretase activity and the level of secreted Ab
(Beel et al., 2008). NMR measurements show that residues that
appear sensitive to cholesterol binding include Phe20, Glu22,
and Gly33. Phe20 is the last residue in the LVFF sequence.
Glu22 is part of the cluster of familial mutations described above.
Gly33 is part of the third GxxxGmotif that has been implicated in
mediating TM helix dimerization of the b-CTF. Depletion of
cholesterol inhibits g-secretase and Ab secretion, while addition
of cholesterol enhances g-secretase activity (Simons et al.,
1998; Wahrle et al., 2002).
In this study, we focus on the structural changes arising from
the A21Gmutation and compare the changes with those caused
by an increase in membrane cholesterol. We first measure how
the A21G and surrounding mutations influence processing of
APP and the b-CTF, and confirm that the A21G mutation in-
creases secreted Ab by g-secretase cleavage. Fourier transform
infrared (FTIR) and NMRmeasurements aremade on C55, corre-
sponding to the first 55 residues of the b-CTF, which includes the
extracellular sequence, TM domain, and a cluster of intracellular
positive charges. The measurements are carried out in model
membrane bilayers in which we can modulate the amount of
cholesterol. These studies address the structure of C55, the
structural changes induced by the A21G mutation, and whether
the presence of cholesterol in membrane bilayers acts synergis-
tically with the A21G mutation.
RESULTS
A21G and LVFF-to-Alanine Mutations Both Lead to an
Increase in Ab Production
We first confirm that the A21G mutation results in an increase in
Ab production and then address whether mutations within the
upstream LVFF sequence result in comparable changes in pro-
cessing. Measurements were made using C55 and the b-CTF
expressed in Chinese hamster ovary (CHO) cells. Measurements
on full-length APP are shown in Figure S1 available online.
Secreted Ab peptides (Ab38, Ab40, and Ab42) were measured
after transfection by multiplex electrochemiluminescence
(ECLIA) assays. Proteolysis of the wild-type (WT) b-CTF results
predominantly in the Ab40 peptide (85%), with smaller amounts
of Ab38 (10%) and Ab42 (5%). Figure 1B shows the level of
secreted Ab peptides produced by g-secretase cleavage as
a percentage relative to WT. Both the A21G mutation and
the LVFF to AAAA mutation increase total Ab production. The
A21G mutation results in a 1.7-fold increase in Ab40. A larger
increase (4.5-fold) is observed in Ab40 for the LVFF to AAAAmu-
tation. There is a striking increase (4-fold) in Ab42 produced rela-
tive toWT in the A21Gmutant. In contrast to the increase of Ab40
and Ab42 with the A21G and LVFF/AAAA mutations, the level of
Ab38 increases for the A21G but not LVFF/AAAA mutation.
We further compared the influence of the A21G and LVFF to
AAAA mutations using C55. Several shorter versions of the
b-CTF have previously been shown to function as g-secretasets reserved
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Figure 2. FTIR Spectroscopy of WT C55 and
Mutants
Comparison of FTIR spectra of WT C55 (A) re-
constituted into DMPC:DMPG bilayers with
spectra of the C55 protein containing the A21G
mutation (B) and alaninemutations at K16 (C), L17-
V18 (D), F19-F20 (E), and E22-D23-V24 (F). For
comparison, FTIR spectra of unlabeled WT C55
are presented in dashed lines in (B)–(F). See also
Figures S2 and S3.
Structure
Conformational Changes Induced by A21Gsubstrates (Funamoto et al., 2004; Yin et al., 2007). C55 is the
C-terminal truncated version of C99 and includes the extracel-
lular and TM regions of the protein. In our structural studies,
we used C55 rather than the full-length C99 protein to allow
selective incorporation of 13C probes for structural studies. In
Figure 1C, we show that both the A21G and the LVFF to AAAA
mutations increase Ab secretion. The changes in Ab secretion
using C55 are similar to those using the full b-CTF, supporting
its use as a model g-secretase substrate.
The LVFF Sequence Is Predominantly b Sheet in
Membrane Bilayers
The processing results show that the extracellular A21G muta-
tion strongly promotes Ab production with both C55 and C99.
To address whether there are structural differences between
WT C55 and C55 with extracellular mutations, we measured
the global secondary structure of C55 reconstituted into model
membrane bilayers using FTIR spectroscopy.
The amide I vibration (1,600–1,700 cm1) is a sensitive marker
of secondary structure. Figure 2A presents the amide I region of
WT C55 in dimyristoyl-phosphocholine:dimyristoyl-phosphogly-
cerol (DMPC:DMPG) bilayers. The FTIR spectrum exhibits bothStructure 22, 387–396, March 4, 2014an intense band at 1,657 cm1 corre-
sponding to a-helical structure and a
weaker band at 1,626 cm1 correspond-
ing to b strand or b sheet structure. Com-
parison of the FTIR spectrum of C55 with
that of a TM peptide having a truncated
extracellular domain (Sato et al., 2009) ar-
gues that the 1,626cm1 bandarises from
the extracellular region of C55 (Figure S2).
To determine which residues are respon-
sible for the 1,626cm1 band,wemutated
the KLVFF and EDV sequences that
bracket A21. Mutations of K16 and
F19-F20 reduce the 1,626 cm1 intensity
consistent with a disruption or reduction
of the b strand secondary structure (Fig-
ure 2). In contrast, the mutation of the
E22-D23-V24 sequence does not strongly
influence the 1,626 cm1 intensity.
These results argue that the extracellular
region upstream of A21 folds into b-struc-
ture. Comparable results are obtained
from FTIR studies on the full-length
b-CTF in the WT, A21G, and LVFF mutant
(Figure 3).Integration of the 1,626 cm1 peak suggests the b sheet
structure is formed by approximately six to eight residues, sug-
gesting that several additional residues may be involved in b
sheet formation. The small 1,695 cm1 resonance observed
for WT C55 is often associated with antiparallel b sheet (Paul
et al., 2004), and the loss of this peak upon mutation of the
LVFF sequence suggests that this region adopts an antiparallel
b sheet fold. One possibility is that the KLVFFAE sequence
forms antiparallel b sheet through intermolecular interactions.
Additional experiments are in progress to test this possibility,
as well as the alternative that residues in the region N-terminal
to KLVFF fold back and form b sheet through intramolecular
interactions.
Earlier solution NMR studies of the full b-CTF and shorter frag-
ments show helical structure of the LVFF sequence (Beel et al.,
2008; Nadezhdin et al., 2012). Our observation of b-structure
within the LVFF sequence argues that this region adopts a
different secondary structure in membrane bilayers than in
detergent/lipid mixtures and detergent micelles (Beel et al.,
2008; Nadezhdin et al., 2012). To test whether detergent interac-
tions induce helical secondary structure, we compared FTIR
spectra of C55 in membrane bilayers, detergent micelles, andª2014 Elsevier Ltd All rights reserved 389
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Figure 3. Comparison of C55 and C99 in DMPC:DMPG Bilayers
(A) Both C55 (solid line) and C99 (dashed line) exhibit resonances characteristic of a-helix (1,657 cm1) and b sheet (1,626 cm1). The C-terminal 44 residues of
C99 are thought to be unstructured and consequently contribute to an overall broadening of the amide I resonance.
(B) The A21G mutation does not significantly influence the FTIR spectra of C55 and C99.
(C) In contrast to the A21Gmutation, the LVFF to AAAAmutation removes the 1,626 cm1 b sheet resonance. The disruption of the 1,626 cm1 resonance in both
C55 and C99 by the LVFF to AAAAmutation is consistent with this region folding into b sheet secondary structure, which is in disagreement with the solution NMR
structures (Barrett et al., 2012; Beel et al., 2008; Nadezhdin et al., 2012) using detergent systems.
Structure
Conformational Changes Induced by A21Gbicelles that have been titrated from bilayer-like structures (q =
2.0) to isotropic detergent-like structures (q = 0.2; Figure S3).
Both the titration of bicelles toward a more detergent-like envi-
ronment or direct comparisons of C55 in bilayers and detergent
micelles show a loss of b sheet structure characterized by the
1,626 cm1 amide I vibration with added detergent.
The A21G Mutation Influences the b Sheet Structure in
Membrane Bilayers
The A21G mutation has only a slight influence on the position of
the 1,626 cm1 band observed in the FTIR spectrum of C55
(Figure 2B). To further explore whether there are local changes
in structure, we compared FTIR spectra of WT and A21G C55
peptides containing specific 13C labels at backbone C = O po-
sitions within the LVFF sequence. The 13C = O labels shift the
amide vibration to lower frequencies. The frequency and inten-
sity of the shifted resonances are sensitive to whether the 13C =
O labeled sites fall within parallel or antiparallel b sheet struc-
ture (Paul et al., 2004; Petty and Decatur, 2005). We selected
F19 and F20 for labeling since mutations at these positions
have a large influence on the 1,626 cm1 resonance. For WT
C55 (Figures 4A and 4C), the incorporation of 13C leads to
splitting of the 1,626 cm1 band into two components at
1,608 cm1 and 1,630 cm1. These shifts are similar to those
described for the KLVFFAED octapeptide (Figure S4), which
forms fibrils with b strands in an antiparallel orientation (Bal-
bach et al., 2000). In contrast, 13C labeling does not cause
the b sheet peak to split in the A21G mutant (Figures 4B and
4D), suggesting that the antiparallel structure observed at posi-
tions F19 and F20 has been disrupted or altered. Previous
studies have shown that the extent of splitting and intensity is
dependent on the position of the 13C = O label. For example,
Axelsen and colleagues (Paul et al., 2004) found that C = O
groups at the edge of b sheet and not involved in hydrogen
bonds had higher frequencies and reduced intensity compared
to hydrogen-bonded C = O groups within b sheet. As a result,
we conclude that A21 is at the edge of the b sheet structure
formed (in part) by the LVFF sequence and attribute the weak
intensity at 1,610 cm1 in the A21G mutant to the 13C = O
carbonyls of F19 and F20.390 Structure 22, 387–396, March 4, 2014 ª2014 Elsevier Ltd All righThe A21G Mutation Increases the Helical Character of
the G25SNKG29 Sequence
Solid-state NMR is complementary to FTIR spectroscopy and al-
lows us to probe local structure. Figure 5 presents the results
from two-dimensional (2D) magic angle spinning NMR spectra
of C55 obtained with dipolar assisted rotational resonance
(DARR). Figures 5A–5D show selected rows from the 2D spectra
corresponding to the 13C = O resonances of F19, F20, G29, and
A30. Comparison of the WT C55 (black) and A21G (red) spectra
illustrates that the A21G mutation induces distinct changes in
chemical shift at some positions, but not others.
Figures 5E and 5F and Table S1 summarize the chemical shifts
of selected Ca and C = O resonances between L17 and I31. The
chemical shifts are plotted as differences from the average res-
idue chemical shifts. Deviations to lower chemical shift values
correspond to b sheet secondary structure. Deviations to higher
chemical shift values correspond to a-helical secondary struc-
ture. For WT C55, the Ca and C = O resonances between L17
and A21 all exhibit negative deviations corresponding to b strand
or sheet structure. The observation of b-structure is consistent
with the FTIR results but contrasts with solution NMR structures
previously determined of this region (Beel et al., 2008; Nadezhdin
et al., 2012). Mutation to A21G results in less negative deviations
of both the Ca and C = O chemical shifts for residues F19–A21,
suggesting that there is a reduction in b-structure. G29 and A30
both exhibit positive deviations consistent with the helical TM
domain beginning at K28. Mutation to A21G does not alter these
latter chemical shifts. The two residues probed between the
LVFF region and the TM domain—V24 and G25—exhibit nega-
tive shifts in WT C55 and positive shifts in the A21Gmutant, sug-
gesting a shift in local secondary structure to a-helix.
The conclusion that the region between G25 and G29 in-
creases in helical structure in the A21G mutant is supported
by DARR NMR measurements between these two residues.
Figure 6A presents DARR NMR spectra of the WT (black) and
A21G C55 (red) peptides 13C labeled at G25 and G29. The dis-
tance between the 13C = O and 13Ca carbons is 5.3 A˚, which
is within the6 A˚ DARR distance range when this region is a-he-
lical. However, this distance is considerably longer (12–13 A˚) in
an extended conformation. Comparison of the two spectrats reserved
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Figure 4. Influence of 13C = O Labeling on
the Amide I Vibration of WT and A21G C55
FTIR spectra are shown of WT C55 (A and C) and
the A21G mutant (B and D) containing 13C = O
labels at F19 (A and B) and F20 (C and D). Spectra
of unlabeled WT C55 are shown in dashed lines in
(A)–(D) for comparison. The incorporation of 13C =
O labels at F19 and F20 only influences the
1,626 cm1 band of WT C55. The C55 peptides
were reconstituted in DMPC:DMPG bilayers. See
also Figure S4.
Structure
Conformational Changes Induced by A21Gshows the appearance of the cross peak (arrow) correlating the
G25 13C = O and G29 13Ca resonances in the A21G mutant. The
appearance of theG25 13C =O toG29 13Ca cross peak is consis-
tent with the stretch of amino acids between these residues
folding into helical structure in the A21G mutant.
The Familial E22Q and D23NMutations Do NotMarkedly
Influence the Extracellular b Sheet Structure
For comparison to A21, we studied the adjacent two positions
(E22 and D23), which are also sites of familial AD mutations, us-
ing FTIR and magic angle spinning (MAS) NMR. In FTIR mea-
surements of C55 containing either the E22Q or D23Nmutations
(Figures S5C and S5D), the incorporation of 13C = O at F19 leads
to a splitting of the 1,626 cm1 band as in WT C55. In MAS NMR
measurements (Figures S5G and S5H), 13C = O labeling at F19,
V24, and G25 in E22Q or D23N C55 also yields spectra similar to
WT C55, and not the large chemical shift changes observed in
the A21G mutant.
These observations highlight the critical position of A21. Mu-
tation of the LVFF sequence just N-terminal to A21 can
decrease the b sheet structure in the extracellular domain and
decrease Ab secretion. In contrast, mutations just C-terminal
to A21 do not significantly influence C55 structure or Ab pro-
cessing. These studies agree with previous results showing
that A21G exhibits distinct phenotypes from familial mutations
at E22 and D23 (De Jonghe et al., 1998; Tian et al., 2010). To
further test the idea that the influence of the A21G mutation is
similar to that of mutations in the LVFF sequence rather than
in the ED sequence, we measured Ab secretion in a series of
A21 mutants. In Figure 7, we show that extension of the LVFF
sequence with an A21F substitution reduces Ab40 and Ab42
secretion, whereas extension of the E22-D23 sequence with
an A21E substitution increases Ab secretion similar to the
observation in the A21G mutant.
Dimerization of WT and A21G C55 Is Mediated by a
GxxxG Interface
In soluble proteins, glycines serve as both helix and b sheet
breakers. However, in TM helices, glycines mediate helix dimer-
ization (Lemmon et al., 1992). The TM region of APP is unusual inStructure 22, 387–396, March 4, 2014containing three consecutive GxxxG
motifs. The A21G mutation generates
a fourth consecutive GxxxG motif. The
observation that the helical secondary
structure increases in the region between
G25 and G29 in the A21G mutant raisesthe possibility that the helical G25xxxG29 motif stabilizes a TM
dimer of C55.
The dimer structure of the TM domain of APP has been re-
ported in both detergent micelles (Nadezhdin et al., 2012) and
membrane bilayers (Sato et al., 2009). In DMPC:DMPG bilayers,
the TM domain dimerizes via the G29xxxG33xxxG37 interface
(Sato et al., 2009). In contrast, the G38xxxA42 sequencemediates
dimerization in dodecylphosphocholine micelles (Nadezhdin
et al., 2012). Two-dimensional DARR NMR experiments were
designed to test if either of these dimer interfaces exists in WT
C55 or in the A21Gmutant. These experiments involve co-mixing
of two different peptides where cross peaks in the 2D spectra are
only observed between heterodimers. Specifically, 13C labels
were selectively incorporated at G33 and A42 in two different
C55 peptides (peptide 1 contains G33 13C = O and A42 13Cb,
and peptide 2 contains G33 13Ca and A42 13C = O). In the heter-
odimer, the G33 residues are closely packed if the G33xxxG37
motif mediates dimerization, whereas the A42 residues are in
close proximity if the G38xxxA42 motif mediates dimerization.
The two WT C55 (or the two 13C-labeled A21G C55) peptides
were reconstituted into 1-palmitoyl-2-oleoyl-phosphocholine:1-
palmitoyl-2-oleoyl-phosphoserine (POPC:POPS) membranes in
equimolar amounts. Figure 8 presents the DARR NMR spectrum
ofWTC55 (black) overlaid with the spectrum of the A21Gmutant
(red). In both the WT and A21G C55 peptides, interpeptide cross
peaks are observed between G33 (13Ca) and G33 (13C = O) (red
box), but not between A42 (13Cb) and A42 (13C = O) (blue box).
No intensity was observed at this position in DARR NMR spectra
of the single peptides containing the G33 13C = O and A42 13Cb
labels alone or the G33 13Ca and A42 13C = O labels alone, and
the cross peak was reduced with the addition of unlabeled pep-
tide (data not shown). The cross peak was only observed when
the two peptides were mixed.
It is possible to relate the intensity of the cross peaks to the
proportion of the peptide associating as dimers if one assumes
that the packing interactions within the dimer structure are the
same for WT C55 and the A21G mutant. In Figure 8A, the cross
peak intensity increases 1.5-fold (relative to the spinning side
band at 26 ppm), suggesting that the Kd decreases for the
A21G mutant of C55 compared to the WT sequence. Sinceª2014 Elsevier Ltd All rights reserved 391
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Figure 5. Comparison of 13C NMRChemical
Shifts between WT and A21G C55
(A–D) Overlap of the carbonyl region of WT C55
(black) and the A21G mutant (red) labeled with
U-13C F19 (A), U-13C F20 (B), U-13C G29 (C), and
U-13C A30 (D). The A21G mutation leads to higher
chemical shift values in the 13C = O carbonyl res-
onances of the adjacent F19 and F20 residues, but
not G29 and A30. Spectra correspond to rows
taken through the Ca diagonal resonance.
(E and F) Carbonyl (E) and Ca (F) carbon chemical
shifts are plotted relative to their average values
obtained from the Biological Magnetic Reso-
nance Bank database (http://www.bmrb.wisc.
edu/ref_info/statful.htm).
See also Table S1.
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Conformational Changes Induced by A21Gdimerization is occurring within the membrane bilayer, it is
possible to define a Kd in terms of the concentration of C55 (rela-
tive to the amount of lipid) that yields equal amounts of monomer
and dimer (Song et al., 2013). If we assume that the cross peak
intensity for dimer corresponds to that for C55 in cholesterol-
containing membranes (Figures 8B and 8C), we can estimate a
Kd of 2 mol% on the basis of the cross peak intensities
observed in Figure 8A. However, it is important to note that
we cannot yet rule out that the increase in cross peak intensity
results in a change in the dimer interface rather than a change
in affinity. In either case, changes in the G33-G33 cross peak in-
tensity show that a change within the structure of the extracel-
lular domain of C55 can be transmitted down to the TM domain
in the absence of the g-secretase complex.
Cholesterol-Rich Bilayers Increase the Helicity of the
TM Domain of WT C55
Both familial mutations and environmental factors influence Ab
generation by g-secretase. For example, a higher concentration
of serum cholesterol has been statistically observed as a risk fac-
tor for AD (Kivipelto et al., 2001). Hypercholesterolemia leads to
an increase in Ab deposition and intraneuronal accumulation of
toxic Ab oligomers in transgenic mice (Umeda et al., 2012).
NMR studies reveal that cholesterol interacts with the b-CTF at
the JM boundary between the extracellular and TM domains in
micelles or detergent/lipid mixtures (Barrett et al., 2012). On
the basis of our observations in the A21G mutant, we investi-
gated the possibility that cholesterol may influence the structure
of the extracellular region of the b-CTF and enhance the struc-
tural changes induced by the A21G mutation.
To test the influence of cholesterol on the structure of the LVFF
sequence, FTIR spectra are presented in Figure S6 of C55 13C-
labeled at F19. We observe a splitting of the 1,626 cm1 band
as for the WT peptide in bilayers without cholesterol, arguing
that cholesterol does not influence the LVFF antiparallel b sheet392 Structure 22, 387–396, March 4, 2014 ª2014 Elsevier Ltd All rights reservedstructure. In contrast, the addition of
cholesterol to POPC:POPS bilayers re-
sults in a 2.2 ppm downfield shift of the
NMR 13C = O resonance of G25, although
without influencing the carbonyl chemi-
cal shifts of F20 or G33, resonances
observed to be sensitive to cholesterolin detergent (Beel et al., 2008). This observation is consistent
with a shift to more helical structure in the region of G25.
The increase in helical secondary structure in the region
between G25 and G29 is supported by intrahelical DARR NMR
measurements. Figure 6B presents the DARR spectra of WT
C55 reconstituted in POPC:POPS (blue) and in POPC:
POPS:cholesterol (red) using the same 13C labeling scheme as
described above. In Figure 6B, the cross peak between G25
13C =O and G29 13Ca is only observed inWTC55 upon the addi-
tion of cholesterol. The appearance of the G25-G29 cross peak
in the A21Gmutant or upon the addition of cholesterol inWT C55
indicates that both conditions induce TM helical structure of the
C55 peptide.
The observation that both the A21G mutant and cholesterol
addition result in a G25-G29 cross peak raises the question as
to whether these two different mechanisms can act synergisti-
cally. Figure 6C presents 2D DARR NMR spectra of the WT
(blue) and A21G C55 (red) peptide in POPC:POPS:cholesterol
bilayers using the same 13C labeling scheme as above. The in-
tensity of the cross peak of the A21G mutant is 1.5-fold higher
in the cholesterol containing membranes consistent with a syn-
ergistic effect.
We next investigatedwhether cholesterol influences themono-
mer-dimer equilibriumof theWTorA21GC55peptides. Figure 8B
presents a comparison of the interhelical G33-G33 dimer cross
peak upon the incorporation of cholesterol into POPC:POPS
membranes. Rows highlighting the interhelical G33 (13Ca)-G33
(13C = O) cross peak at 46.2 ppm are shown for WT C55 (black)
reconstituted into POPC:POPS:cholesterol bilayers and for the
A21G mutant (red) reconstituted into POPC:POPS:cholesterol
bilayers. The cross peak intensity for WT C55 with cholesterol is
approximately the same as that for the A21G peptide without
cholesterol in POPC:POPS membranes, suggesting that the
monomer-dimer equilibrium is approximately the same. When
the A21G mutant is incorporated into POPC:POPS:cholesterol
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Figure 6. The 13C DARR NMR Measure-
ments between G25 and G29 in WT and
A21G C55
Regions of the 2D DARR NMR spectra are shown
corresponding to C = O to Ca crosspeaks.
(A) WT (blue) and A21G (red) C55 containing
13C-labels at G25 (13C = O) and G29 (13Ca) were
reconstituted into DMPC:DMPG bilayers. An in-
terresidue cross peak (arrow) between these 13C
sites is only observed for the A21G mutant and
corresponds to the formation of helical secondary
structure.
(B) DARR NMR measurements on WT C55
in POPC:POPS (blue) and WT C55 in POPC:
POPS:cholesterol (red) using the same G25 (13C =
O) and G29 (13Ca) labeled peptide as in (A).
(C) DARR NMRmeasurements onWT C55 (blue) and A21G C55 (red) peptide in POPC:POPS:cholesterol bilayers. Upon addition of cholesterol, the cross peak is
observed for both the WT and mutant peptides. The spectra are scaled to the strong 1,2-13C L17 cross peak at 173 ppm corresponding to directly bonded
carbons, which is not expected to change intensity in these spectra.
See also Figure S6.
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Conformational Changes Induced by A21Gmembranes (red), the cross peak intensity increases 2-fold,
consistent with a synergistic effect of A21G and cholesterol. Fig-
ure 8C illustrates the influence of cholesterol on the G33-G33
cross peak intensity as cholesterol is increased in POPC:POPS
bilayers from 0 to 30 mol%. As discussed for the A21Gmutation,
the increase in cross peak intensity may be due to a change
in conformation rather than affinity. However, both A21G and
cholesterol appear tohave thesame influenceonTM interactions.
DISCUSSION
TheStructure of APP near theRegion of A21GRegulates
Processing
The A21G mutation has a strong influence on intramembranous
processing by the g-secretase complex. We address how the
loss of a single methyl group alters the structure of the extracel-
lular region and TM domain using FTIR and NMR spectroscopy,
and we propose how these changes are linked to processing of
the b-CTF. FTIR and NMRmeasurements of C55 in bilayers pro-
vide evidence that b strand secondary structure is adopted in the
extracellular region of the b-CTF and that the A21G mutation in-
fluences the upstream LVFF sequence (particularly F19 and F20)
and the downstream GSNKG sequence, with a small effect on
TM dimerization. These data emphasize the ability of glycine to
destabilize b sheet structure (Minor and Kim, 1994) and to stabi-
lize TM dimers through GxxxG motifs (Lemmon et al., 1992).
The Flemish mutation was first described by Hendriks et al.
(1992) and later was shown to increase Ab production by
2-fold (De Jonghe et al., 1998). Yi and colleagues (Tian et al.,
2010) found that the extracellular LVFFAED sequence was inhib-
itory to the activity of g-secretase. They observed that deletion of
this sequence resulted in a 10-fold increase in secreted Ab40. To
more directly test the role of the LVFF sequence in regulating Ab
secretion, we substituted the LVFF sequence with four alanine
residues and found that the mutation increases Ab secretion
(Ab40 and Ab42) 4.5-fold, considerably less than the increase
observed when the sequence is deleted, but much greater
than the 1.7 fold increase due to the A21G mutation (Figure 1).
Our studies suggest that A21 is at the edge of the b sheet fold
in the extracellular domain of the b-CTF. The FTIR measure-Structure 22,ments reveal only modest changes in the 1,626 cm1 band
upon mutation of A21 to glycine. In contrast, the A21G mutation
results in large changes in the chemical shifts at F19, F20, and
G25, consistent with unraveling of the b sheet structure at the
end of the LVFF sequence and the formation of helical secondary
structure in the GSNKG sequence. Strikingly, mutation of A21,
but not the adjacent E22 and D23 residues, induces structural
changes in the LVFF and GSNKG sequences and an increase
in Ab. A21 appears to be at a breakpoint between a well-defined
b strand and the TM helix; extension of the LVFF sequence with
an A21F substitution reduces Ab secretion, whereas extension of
the E22-D23 sequence with an A21E substitution increases Ab
secretion (Figure 7).
The WT and A21G C55 Dimerize through the GxxxG and
Not the GxxxA Interface
The observation that the A21Gmutation introduces an additional
GxxxGmotif into theb-CTFand that theG25xxxG29 sequencebe-
comes more helical suggests that the A21G mutation influences
TM dimerization. Mutation of the consecutive G29xxxG33xxxG37
motifs supports the idea that TM dimerization influences pro-
cessing (Kienlen-Campard et al., 2008; Munter et al., 2007).
Recently, the dimer structure of residues Q15–K53 was deter-
mined in detergentmicelles (Nadezhdin et al., 2012). Surprisingly,
the dimer interface in their NMR structure was formed from the
G38xxxA42 sequence rather than G33xxxG37.
Above we show unambiguously that the A21G dimer is medi-
ated by the G33xxxG37 interface. The strong G33 Ca and G33
C = O cross peak can only be explained by a well-defined dimer
structure. The observation that the A21G mutation has only a
small influence on the G33-G33 cross peak intensity implies
that the large influence of the mutation on processing is associ-
ated with the structural changes in the extracellular domain
rather than with dimerization. These results support the con-
clusions of Tian et al. (2010) that the LVFFAED sequence is
inhibitory.
The A21G Mutation and Cholesterol Act Synergistically
Many cellular factors appear to influence the overall level of
secreted Ab peptides and the Ab42/Ab40 ratio, including the387–396, March 4, 2014 ª2014 Elsevier Ltd All rights reserved 393
Figure 7. Influence of b-CTF Processing upon Substitution of Ala21
with Aromatic and Charged Residues
The A21F mutation reduces Ab40 and Ab42 production. This mutation re-
places A21 with a hydrophobic phenylalanine identical to the last residue in the
upstream LVFF sequence; A21E increases both Ab40 and Ab42 secretion. The
A21Emutation replaces A21 with a residue identical to the downstreamGlu22.
Values are the means ± SE, n > 5; *p < 0.05; **p < 0.01; ***p < 0.001, compared
with control. See also Figure S5.
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Conformational Changes Induced by A21Gpresence of cholesterol (Beel et al., 2008; Simons et al., 1998;
Wahrle et al., 2002). Upon the addition of cholesterol to model
membranes, we observe an increase in a-helical secondary
structure, and in the A21G mutant, a shift of the monomer-dimer
equilibrium toward dimer or reorientation of the dimer interface
to strengthen the G33-G33 contact. It is known that cholesterol
increases the thickness of the bilayer, and we infer that this in-
duces an increase in the helical structure between G25 and
G29, in a fashion similar to that of A21G. In neuronal axons,
the concentration of cholesterol is estimated to be 15% (Cal-
deron et al., 1995). These results suggest that dimerization is
facilitated by the G25xxxG29 interface in A21G and that choles-
terol helps stabilize this interface. Together, our studies and
recent studies by Sanders and coworkers (Song et al., 2013) indi-
cate that dimerization of theWTTM sequence of APP is weak but
can be modulated by protein concentration, mutation, and the
membrane environment.
The results on the A21Gmutation and added cholesterol point
to a simple model in which structural changes in the extracellular
sequence (LVFFAEDVGSNK) lead to a reduction of inhibitory in-
teractions and influence dimerization. The nature of the inhibitory
interactions may originate with interactions between the LVFF
sequence and g-secretase (Tian et al., 2010) or with the mem-
brane surface (Beel et al., 2008). The convergence of results
reveals that both mutational and environmental factors can
induce conformational changes in g-secretase substrates that
have implications in AD.
EXPERIMENTAL PROCEDURES
Materials
The 13C-amino acids were obtained from Cambridge Isotope Laboratories.
Detergents were obtained from Sigma-Aldrich and lipids from Avanti Polar
Lipids. Human APP-specific antibody (WO-2) was obtained from Millipore.
All cell culture reagents were from Invitrogen. The plasmids used to express
human APP695 or b-CTF in eukaryotic cells have been previously described
(Kienlen-Campard et al., 2008). The different mutants were generated by
site-directed mutagenesis according to manufacturer’s instructions (Quick-
Change, Stratagene).
Cell Cultures and Transfection
CHO cells were cultured in F12 medium supplemented with 10% fetal bovine
serum and antibiotics at 37C and 5% CO2 and transfected 24 hours after394 Structure 22, 387–396, March 4, 2014 ª2014 Elsevier Ltd All righseeding as previously described (Kienlen-Campard et al., 2008). Western blot-
ting was performed on cell lysates (10 mg protein). Membranes were incubated
at 4C overnight with human APP-specific WO-2 monoclonal antibody
(1:2,000), washed and incubated with 1:10,000 secondary anti-mouse anti-
body conjugated to horseradish peroxidase, followed by enhanced chemilu-
minescence revelation (Amersham). Ab production was monitored in the
culture media 48 hours after transfection (Kienlen-Campard et al., 2008).
Briefly, samples were cleared by centrifugation (12,000 g, 3 min, 4C). Ab38/
Ab40/Ab42 and soluble APPa/b were quantified in 25 ml of cellular medium
by multiplex ECLIA assay according to the manufacturer’s instructions
(MesoScale Discovery).
Peptide Synthesis, Purification, and Reconstitution of C55 into
Bicelles
C55 peptides (Asp1-Lys55) corresponding to the TM and JM regions of APP
were synthesized by solid-phase methods (Keck Facility, Yale University).
The purity was confirmed with MALDI-TOF mass spectrometry and analytical
reverse-phase high-pressure liquid chromatography. For reconstitution into
bicelles, the C55 peptides were refolded with 16 mM dihexoylphosphocholine
(DHPC). The fractions containing purified protein were collected on the basis of
the absorbance at 280 nm. The peptide-to-lipid ratio was 1:50 in bicelles with
different q values (0.25, 0.35, 1.0, and 2.0) by adding proper amounts of lipids
in the protein stock solutions. The samples of peptides reconstituted into
bicelles were prepared by several cool-and-thaw cycles until the samples
appeared clear.
Protein Overexpression and Purification
The C55 sequence was subcloned into a pET21a vector and expressed
with an N-terminal methionine and a C-terminal linker plus His-tag
(KLAAALEHHHHHH). The C55 protein was purified using a Nickel nitrilotriace-
tic acid column. Cell pellets were washed three times with the 35 ml of lysis
buffer until the washed solution became clear. The pellets were then dis-
solved in 35 ml of urea/SDS buffer (20 mM Tris, 150 mM NaCl, 8 M urea,
0.2% SDS, pH 7.8) and mixed overnight at room temperature. The resulting
solution was centrifuged at 25,000 g for 20 min. The supernatants were
pooled with the pre-equilibrium Nickel beads and mixed for 2 hours at room
temperature. The beads were then washed with urea/SDS buffer, and the
proteins were eluted with 250 mM imidazole in Tris-buffered saline solution
(pH 7.8) containing octyl-b-D-glucoside. The eluted fractions were collected
and checked by SDS-PAGE. The protein purity was further confirmed with
mass spectroscopy.
Reconstitution of C55 into Bicelles
The C55 peptides were eluted from the Ni column and refolded with 16 mM
DHPC (Avanti lipids) in the elution buffer as described above. The fractions
containing purified protein were collected on the basis of the absorbance at
260–280 nm. The peptide-to-lipid ratio was 1:50 in bicelles with different q
values (0.25, 0.35, 1.0, and 2.0) by adding proper amounts of lipids in the pro-
tein stock solutions. The samples of peptides reconstituted into bicelles were
prepared as described (Lu et al., 2012) by several cool-and-thaw cycles until
the samples appeared clear.
Reconstitution of C55 into Membrane Bilayers
The C55 peptides were cosolubilized with lipid and octyl-b-glucoside in hexa-
fluoroisopropanol. The peptide:lipid molar ratio was 1:50 and the molar ratios
between lipids were as follows: DMPC:DMPG, 10:3; POPC:POPS,10:3; or
POPC:POPS:cholesterol, 10:3:5.6. The solution was incubated for 3 hours at
30C, after which the solvent was removed under a stream of argon gas and
then under vacuum overnight. Then 2-(N-morpholino)ethanesulfonic acid
(MES) buffer (5 mM MES, 50 mM NaCl, pH 6.2) was added to the solid from
the previous step and gently mixed at 30C for 6 hours. The octyl-b-glucoside
was removed by dialysis (Smith et al., 2002). DMPC and POPC are represen-
tative lipids with saturated and unsaturated fatty acyl chains, respectively,
while the DMPG and POPS headgroups introduce an overall negative mem-
brane charge similar to that in cellular plasma membranes. DMPC can be
titrated with DHPC to convert from membrane bilayers to isotropic (deter-
gent-like) bicelles. POPC is abundant in plasma membranes and exhibits a
continuous transition from a liquid disordered state to liquid ordered statets reserved
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Figure 8. Interhelical 13C DARR NMR
Measurements of WT and A21G C55 Recon-
stituted into POPC:POPS Bilayers
Two WT C55 or two A21G C55 peptides
were mixed in equal molar amounts to establish
the dimer interface, either G29xxxG33xxxG37 or
G38xxxA42.
(A) 1D and 2D DARR NMR spectra of WT C55
(black) and A21G C55 (red) are overlapped. Only
cross peaks resulting from G33 on different pep-
tides (i.e., G33 Ca to G33 C = O) are observed.
Cross peaks are not observed between A42 on
different peptides (i.e., A42 Cb to A42 C = O, blue
box).
(B) 1D and 2D DARR NMR spectra of WT C55
(black) and A21G C55 (red) are overlapped in
POPC:POPS membranes with 30 mol% choles-
terol. Rows are shown through the G33 C = O
diagonal resonance. The resonance at26 ppm is
a spinning side band and serves as an internal
control for comparing relative intensity changes
between spectra.
(C) Influence of the G33 Ca to G33 C = O cross
peak intensity on cholesterol content for A21G
C55. The content of the cholesterol in POPC:POPS
membranes was varied from 0%–30%. Error bars
reflect the noise level of the measurements.
(D) Molecular model of the C55 TM dimer medi-
ated by the G29xxxG33xxxG37 interface (red). A42
(blue) is oriented away from the interface.
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Conformational Changes Induced by A21Gwith the addition of cholesterol (London, 2005). In our studies, only small differ-
enceswere observed in the FTIR andNMR spectra betweenC55 reconstituted
into POPC:POPS or DMPC:DMPG bilayers. The only marked differences were
observed upon titration of cholesterol into the POPC:POPS membranes.FTIR Spectroscopy
Polarized attenuated total reflection (ATR) FTIR spectra were obtained on a
Bruker IFS 66V/S spectrometer. ATR-FTIR spectroscopy was used to charac-
terize the global secondary structure and the orientation of the TM domain of
C55 in bilayers. TheWT and A21G C55 peptides reconstituted in bilayers were
layered on a germanium plate and bulk water removed by a slow flow of nitro-
gen gas. Similar dichroic ratios of the 1,657 cm1 band of 3.2–3.3 are observed
for both peptides regardless of the lipid mixture used in these studies. The high
dichroic ratio is consistent with an orientation of the TM a-helix of20 relative
to the bilayer normal and indicates that both peptides can be reconstituted into
bilayers by detergent dialysis.Solid-State NMR Spectroscopy
NMR experiments were performed at a 13C frequency of 125 MHz on a Bruker
AVANCE spectrometer. The MAS spinning rate was set to 9–11 kHz (±5 Hz).
The ramped amplitude cross polarization contact time was 2 ms. Two-pulse
phase-modulated decoupling was used during the evolution and acquisition
periods with a radiofrequency field strength of 80 kHz. Internuclear 13C.13C
distance constraints were obtained from 2D DARR NMR experiments (Take-
goshi et al., 2001) using a mixing time of 600 ms. The sample temperature
was maintained at 198 K (±2 K). The 13C chemical shifts are referenced to
external 4,4-dimethyl-4-silapentane-1-sulfonic acid.Structure 22,SUPPLEMENTAL INFORMATION
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